Reijo Pera

In vitro fertilization technique receives patent

Last December CIRM grantee Renee Reijo Pera spoke to the CIRM governing board about her work identifying which in vitro fertilization embryos were most likely to result in a successful pregnancy (you can watch that video here).

IVF embryo donation approach gives donors privacy, time

A new paper by CIRM grantees at Stanford University is reporting on an innovative way of ensuring that people considering donating left over in vitro fertilization embryos to research make the best possible decision for themselves. The paper was published on April 8 in Cell Stem Cell.

Parkinson's disease modeled for the first time in a lab dish

CIRM grantees at Stanford University and The Parkinson's Institute have an exciting Cell Stem Cell paper out today showing that they can mimic Parkinson's disease in a lab dish using reprogrammed iPS cells.

Nobel-winning IVF work laid groundwork for stem cell research

On Monday the Nobel Prize in Physiology or Medicine went to Robert Edwards for his efforts to make in vitro fertilization a reality. The Nobel Prize-winning discovery not only allowed millions of couples to start families, it opened up the field of stem cell research.

According to the Nobel Prize press release:

New Stem Cell Lines Created from Testes Biopsy

Researchers at Stanford University School of Medicine have created new stem cell lines from cells found in the human testes. Like embryonic stem cells, these cell lines are pluripotent, which means that they can form all cell types in the adult body. The work follows similar research finding that adult stem cells in mouse testes can be reprogrammed into pluripotent cells. However, the researchers found that the cells differed from embryonic stem cells in several important ways.

New Embryonic Stem Cell Lines Avoid Animal Products

Researchers at Stanford University School of Medicine derived new human embryonic stem cell lines using minimal animal products. Although numerous groups have derived stem cell lines, most were generated in the presence of animal serum and animal-derived feeder cells. These animal products are a concern because they may cause the stem cells to produce an immune response when transplanted into humans and may induce biological changes especially to the genome.

Subscribe to RSS - Reijo Pera

© 2013 California Institute for Regenerative Medicine